"Watchful Waiting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clinical management approach wherein immediate therapy is not provided but there is a period of observation during which periodic tests monitor patient and the progression of the illness. (Driffield T, Smith PC Med Decis Making. 2007 Mar-Apr;27(2):178-88)
Descriptor ID |
D057832
|
MeSH Number(s) |
N04.761.559.590.900
|
Concept/Terms |
Watchful Waiting- Watchful Waiting
- Waiting, Watchful
- Waitings, Watchful
- Watchful Waitings
|
Below are MeSH descriptors whose meaning is more general than "Watchful Waiting".
Below are MeSH descriptors whose meaning is more specific than "Watchful Waiting".
This graph shows the total number of publications written about "Watchful Waiting" by people in this website by year, and whether "Watchful Waiting" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 0 | 1 |
2010 | 0 | 2 | 2 |
2011 | 2 | 2 | 4 |
2012 | 3 | 4 | 7 |
2013 | 5 | 5 | 10 |
2014 | 4 | 3 | 7 |
2015 | 8 | 2 | 10 |
2016 | 5 | 6 | 11 |
2017 | 8 | 5 | 13 |
2018 | 3 | 7 | 10 |
2019 | 7 | 8 | 15 |
2020 | 4 | 6 | 10 |
2021 | 5 | 7 | 12 |
2022 | 2 | 1 | 3 |
2023 | 0 | 5 | 5 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Watchful Waiting" by people in Profiles.
-
Functional Outcomes After Localized Prostate Cancer Treatment. JAMA. 2024 01 23; 331(4):302-317.
-
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial. Lancet. 2023 11 18; 402(10415):1835-1847.
-
Hypospadias prevalence by severity and associated risk factors: A population-based active surveillance analysis. J Pediatr Urol. 2023 12; 19(6):720.e1-720.e9.
-
Fetoscopic laser photocoagulation versus expectant management for stage I twin-to-twin transfusion syndrome: A systematic review and meta-analysis. Prenat Diagn. 2023 08; 43(9):1229-1238.
-
EBNEO commentary: Expectant management or early ibuprofen for patent ductus arteriosus. Acta Paediatr. 2023 08; 112(8):1822-1823.
-
Laser therapy versus expectant management for selective fetal growth restriction in monochorionic twins: A systematic review. Prenat Diagn. 2023 05; 43(5):687-698.
-
ACR Appropriateness Criteria? Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update. J Am Coll Radiol. 2022 05; 19(5S):S156-S174.
-
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance. Cancer Med. 2022 11; 11(22):4332-4340.
-
Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study. BMJ Open. 2022 04 05; 12(4):e057693.
-
Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysis. Ann Surg. 2022 03 01; 275(3):467-476.